ScienceHong Kong targets biomedicine powerhouse status in debut five-year plan
Hong Kong’s first five-year plan, due next week, is expected to highlight biomedicine as officials signal closer medical cooperation across the Greater Bay Area. Global pharmaceutical company GSK also stressed its interest in expanding its role in the region’s biotech development at the BIOHK conference.
S
South China Morning Post★★☆☆☆2026-09-09 09:27Original
Hong Kong targets biomedicine powerhouse status in debut five-year plan
Science